Tagged With Aetna

CVS jumps on earnings beat as its merger with insurance company Aetna begins to pay off

Dispensed: Insurers will now cover a $2.1 million drug for kids, the pharma industry's AI ambitions, and a caravan to Canada in search of cheaper insulin

Dispensed: Introducing Business Insider's 10 people transforming healthcare

Dispensed: Layoffs at Clover Health, a troubling marijuana-linked syndrome, and what's ahead for the exploding gene therapy field

Goldman Sachs job cuts — How to pitch VCs — Walmart's trucking ambitions

Dispensed: Prescribing guidelines at a buzzy men's health startup, a depression drug moves one step closer to approval, and a leaked letter that's fuelling a fight over high drug prices

CVS is revamping its stores to take on Amazon and prepare for the future of healthcare. Take a look inside.

A huge health insurer is teaming up with Apple in a bet that an app and a smartwatch can make you healthier

CVS officially completed its $70 billion deal with Aetna almost a year after it was announced, creating a new kind of healthcare company

CVS beats, says Aetna deal will close before Thanksgiving

2 massive healthcare deals just got approved by the DOJ — and they will change healthcare as we know it

How a harrowing, near-death experience led Aetna's CEO to introduce yoga and meditation for the company's employees

The DOJ is reportedly close to approving 2 healthcare megamergers

The CEO of a company often called the future of healthcare reveals why medical care is moving into homes and out of hospitals

Walmart slides amid reports it's in talks to buy health insurer Humana

The biggest healthcare mergers of the year shouldn't happen -- period

CVS is borrowing a near-record $40 billion to bankroll a deal that hasn't even been approved

CVS has a $2.1 billion reason to worry about its deal with Aetna falling through

Aetna wants to create a 'Genius Bar' at CVS, and it could forever change the way Americans access healthcare

The CEO of Aetna is going to make a huge amount of money if the $69 billion deal with CVS closes